Form 4: ANI Pharmaceuticals SVP & CFO Stephen P. Carey Reports Stock Transaction
SEC Form 4 Filing
Stephen P. Carey, SVP & CFO of ANI Pharmaceuticals, reports a transaction involving the withholding of shares for tax purposes related to the vesting of restricted stock.
Summary
- On March 7, 2025, Stephen P. Carey, SVP & CFO of ANI Pharmaceuticals, had 5,150 shares of common stock withheld for tax purposes.
- The shares were withheld at a price of $60.62 per share.
- This transaction occurred in connection with the vesting of 11,292 shares of restricted stock, the grant of which was previously reported.
- Following the transaction, Carey directly owns 187,073 shares of ANI Pharmaceuticals common stock.
Sentiment
Score: 7
Explanation: The document is a standard regulatory filing related to stock transactions. It doesn't contain any information that would significantly impact investor sentiment positively or negatively. It is a neutral event.
Industry Context
Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders. This filing indicates a standard tax withholding procedure related to the vesting of restricted stock.
Stakeholder Impact
- The transaction has a minimal direct impact on stakeholders, as it is a routine tax withholding related to executive compensation.
Key Dates
| Date | Description |
|---|---|
| 03/07/2025 | Date of the stock transaction (share withholding for tax purposes). |
| 03/14/2025 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.